Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 2, 2011, Pages 439-443

  Brown, Morgan L ^a   Schaff, Hartzell V ^b   Dearani, Joseph A ^b   Li, Zhuo ^b   Nishimura, Rick A ^b   Ommen, Steve R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MUSCLE RESECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; TRANSAORTIC SEPTAL MYECTOMY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ARTERY DISEASE; DATABASES AS TOPIC; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78751612416     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.04.046     Document Type: Article

References (14)

1. S.R. Ommen, B.J. Maron, I. Olivotto, M.S. Maron, F. Cecchi, and S. Betocchi Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476
2. N.G. Smedira, B.W. Lytle, H.M. Lever, J. Rejeswaran, G. Krishnaswamy, and R.K. Kaple Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy Ann Thorac Surg 85 2008 127 133
3. B.J. Maron Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206
4. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
5. Lang MB, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Available at: http://www.asefiles.org/ChamberQuantification.pdf
6. C. Autore, P. Bernabo, C. Stella Barilla, P. Bruzzi, and P. Spirito The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms J Am Coll Cardiol 45 2005 1076 1080
7. P. Sorajja, R.A. Nishimura, S.R. Ommen, M.J. Ackerman, A.J. Tajik, and B.J. Gersh Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy J Am Soc Echocardiogr 19 2006 788 795
8. M.S. Maron, I. Olivotto, S. Betocchi, S.A. Casey, J.R. Lesser, and M.A. Losi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
9. P.M. Elliott, J.R. Gimeno, M.T. Tomé, J. Shah, D. Ward, and R. Thaman Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy Eur Heart J 27 2006 1933 1941
10. P.F. Monteiro, S.R. Ommen, B.J. Bersh, J.A. Dearani, H.V. Schaff, and R.A. Nishimura Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling Am J Cardiol 100 2007 1776 1778
11. S.J. Deb, H.V. Schaff, J.A. Dearani, R.A. Nishimura, and S.R. Ommen Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy Ann Thorac Surg 78 2004 2118 2122
12. C.J. McLeod, S.R. Ommen, M.J. Ackerman, P.L. Weivoda, W.K. Shen, and J.A. Dearani Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart J 28 2007 2583 2588
13. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with The American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
14. P. Sorajja, S.R. Ommen, R.A. Nishimura, B.J. Gersh, P.B. Berger, and A.J. Tajik Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease Circulation 108 2003 2342 2348